Trial
NCT01201850
The Role of Bevacizumab in the Treatment of Radiation Necrosis in Children With Central Nervous System Tumors
UnknownTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Colorado, Denver
Collaborators
Genentech, Inc.
Condition
Radiation Necrosis
Intervention
Bevacizumab (Avastin®)
Why stopped
Poor accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-05-19